ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1546 • 2012 ACR/ARHP Annual Meeting

    Rhinosinusits and Nasal Polyps in the Diagnosis and Follow up of Patients with Eosinophilic Granulomatosis with Polyangitis (ex-Churg Strauss Syndrome)

    Chiara Baldini1, Veronica Seccia2, Manuela Latorre3, Paolo Iannicelli2, Daniela Martini1, Francesco Ferro1, Nicoletta Luciano1, Antonio Tavoni4, Stefano Sellari Franceschini2 and Stefano Bombardieri5, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2Unit of Otorhinolaryngology, Department of Neuroscience, University of Pisa, Pisa, Italy, Pisa, Italy, 3University of Pisa, Pneumology Unit, Pisa, Italy, 4University of Pisa, Immunoallergology Unit, Pisa, Italy, 5Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy

    Background/Purpose: Chronic rhinosinusitis with nasal polyposis (CRSwP) is a common manifestation  of granulomatosis with polyangitis  (EGPA), and may represent an invalidating feature of the disease,…
  • Abstract Number: 1547 • 2012 ACR/ARHP Annual Meeting

    A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy

    Dario Roccatello1, Savino Sciascia2, Simone Baldovino3 and Daniela Rossi1, 1Department of Rare, Immunologic, Hematologic and Immunohematologic Diseases, Centro di Immunopatologia e Documentazione su Malattie rare, Torino, Italy, 2Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 3Centro di Ricerche di Immunologia Clinica ed Immunopatologia e Documentazione su Malattie Rare (CMID), Università di Torino, Torino, Italy

    Background/Purpose: Mixed cryoglobulinemia syndrome (MCs) is a systemic vasculitis characterized by multiple organ involvement due to the vascular deposition of immune-complexes, mainly the cryoglobulins. B…
  • Abstract Number: 1548 • 2012 ACR/ARHP Annual Meeting

    Cutaneous Vasculitis as a Paraneoplastic Syndrome

    Javier Loricera1, Vanesa Calvo-Rio2, Francisco Ortiz Sanjuan3, Marcos Antonio Gonzalez-Lopez4, Hector Fernandez-Llaca4, Javier Rueda-Gotor2, Carmen Gonzalez-Vela5, Cristina Mata-Arnaiz3, Miguel A. Gonzalez-Gay2 and Ricardo Blanco2, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, 2Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 4Dermatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 5Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain

    Background/Purpose: Cutaneous Leukocytoclastic Vasculitis (CLV) may be associated with malignancies, and sometimes it behaves as a paraneoplastic syndrome. This association has been reported in a…
  • Abstract Number: 1549 • 2012 ACR/ARHP Annual Meeting

    Sibling Relative Risk and Heritability of Kawasaki Disease: A Nationwide Population Study in Taiwan

    I-Jun Chou1, Chang-Fu Kuo2, Jing-Long Huang3, Chang-Teng Wu1, Shao-Hsuan Hsia1 and Hsiao-Chun Chang4, 1Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 2Academic Rheumatology, School of Clinical Sciences, University of Nottingham, Nottingham, United Kingdom, 3Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 4Division of Rheumatology, Immunology and Allergy, Chang Gung Memorial Hospital, Taoyuan, Taiwan

    Background/Purpose: Kawasaki disease (KD) is an autoimmune disease involving primarily medium-sized vessels and is the leading cause of acquired cardiac disease in children. The pathogenesis…
  • Abstract Number: 1550 • 2012 ACR/ARHP Annual Meeting

    Long-Term Outcomes of Patients with Reversible Cerebral Vasoconstriction Syndromes (RCVS)

    Seby John1, Leonard H. Calabrese2, Stewart Tepper3, Mark Stillman3, Ken Uchino1 and Rula Hajj-Ali3, 1Neurology, Cleveland Clinic Foundation, Cleveland, OH, 2Rheumatic & Immunologic Dis, Cleveland Clinic Foundation, Cleveland, OH, 3Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: RCVS is a syndrome characterized by acute onset of severe headaches, with or without neurologic deficit with evidence of reversible cerebral vasoconstriction. Natural history…
  • Abstract Number: 1551 • 2012 ACR/ARHP Annual Meeting

    Primary Angiitis of the Central Nervous System: Description of the First 52 Adult Patients Enrolled in the French COVAC’ Cohort

    Hubert de Boysson1, Mathieu Zuber2, Olivier Naggara3, Jean-Philippe Neau4, Françoise Gray5, Marie-Germaine Bousser6, Isabelle Crassard6, Emmanuel Touze7, Pierre-Olivier Couraud8, Philippe Kerschen9, Catherine Oppenheim3, Olivier Detante10, Anthony Faivre11, Nicolas Gaillard12, Caroline Arquizan13, Boris Bienvenu14, Antoine Neel15, Loic Guillevin16, Christian Pagnoux17 and French Vasculitis Study Group and NeuroVascular Society18, 1Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, 2Department of Neurology, Groupe Hospitalier Saint-Joseph, Université Paris Descartes, Paris, France, 3Department of Neuroradiology, Hôpital Sainte-Anne, Paris, France, 4Department of Neurology, Centre Hospitalier Universitaire La Milétrie, Poitiers, France, 5Department of Pathology, APHP Hôpital Lariboisière, Université Paris Diderot, Paris, France, 6Department of Neurology, APHP Hôpital Lariboisière, Université Paris Diderot, Paris, France, 7Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, Paris, France, 8Department of Cellular Biology, Institut Cochin, Paris, France, 9Department of Neurology, Centre Hospitalier Universitaire Henri Mondor, Créteil, France, 10Department of Neurology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France, 11Department of Neurology, Hôpital d'Instruction des Armées Saint-Anne, Toulon, France, 12Department of Neurology, Centre Hospitalier de Perpignan, Perpignan, France, 13Department of Neurology, Hôpital Gui de Chauliac, Université Montpellier, Montpellier, France, 14Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, 15Department of Internal Medicine, Centre Hospitalier Universitaire de Nantes, Nantes, France, 16Internal Medicine, Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, 17Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, 18Paris, France

    Background/Purpose: Primary angiitis of the central nervous system (PACNS) is rare and only 1 pediatric and 1 adult large cohorts including >30 PACNS patients have…
  • Abstract Number: 1552 • 2012 ACR/ARHP Annual Meeting

    Clinical Correlates, Treatment Outcomes and Predictors of Vasculitis Associated with Rheumatoid Arthritis in the ‘Biologic Era’ : A Case-Control Study

    Ashima Makol1, Cynthia S. Crowson2, Eric L. Matteson3 and Kenneth J. Warrington1, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: 1.To determine the clinical presentation, treatment and outcomes of vasculitis (RV) associated with rheumatoid arthritis (RA) in the era of biologic use. 2. To…
  • Abstract Number: 1553 • 2012 ACR/ARHP Annual Meeting

    The Effect of Knee Replacement On Participation Outcomes: The Multicenter Osteoarthritis Study and Osteoarthritis Initiative

    Jessica L. Maxwell1, Jingbo Niu2, Julie J. Keysor3, Tuhina Neogi4, Tianzhong Yang5, Michael C. Nevitt6, Jasvinder A. Singh7, Laura Frey-Law8 and David T. Felson9, 1Physical Therapy & Athletic Training, Boston Univ Sargent College, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Physical Therapy, Boston University Sargent College, Boston, MA, 4Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology, Boston University School of Medicine, Boston, MA, 6Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 7Department of Medicine, University of Alabama, Tuscaloosa, AL, 8University of Iowa, Iowa City, IA, 9Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Little research has explored participation outcomes, defined as involvement in life situations, among persons following knee replacement (KR).  We recently reported (OARSI 2012) that…
  • Abstract Number: 1554 • 2012 ACR/ARHP Annual Meeting

    Clusters of Fatigue- a Comparison Between Persons with Systemic Lupus Erythematosus and Age and Gender Matched Controls

    Susanne Pettersson1, Karin Eriksson2, Carina Boström2, Elisabet Svenungsson1, Iva Gunnarsson1 and Elisabet MB Welin Henriksson3, 1Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 2Department of Neurobiology, Care Sciences and Society,, Division of Physiotherapy, Karolinska Institutet Huddinge, Stockholm, Sweden, 3Medicine, Karolinska Institutet Rheum, Stockholm, Sweden

    Background/Purpose: The aim (1) of this study was to explore fatigue in patients with SLE with age and gender match controls using cluster analysis and…
  • Abstract Number: 1555 • 2012 ACR/ARHP Annual Meeting

    Minimal Clinically Important Difference for Seven Measures of Fatigue in Patients with Systemic Lupus Erythematosus – Results From a Swedish Setting

    Susanne Pettersson1, Ingrid E. Lundberg2 and Elisabet MB Welin Henriksson3, 1Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 3Medicine, Karolinska Institutet Rheum, Stockholm, Sweden

    Background/Purpose: The objective of this study was to estimate the minimal clinically important difference (MCID) of seven self-administered measures assessing fatigue in persons with systemic…
  • Abstract Number: 1556 • 2012 ACR/ARHP Annual Meeting

    The Effect of Ginger Therapy On Symptoms of Osteoarthritis: An Open Pilot Study

    Tessa Therkleson, Nursing, Edith Cowan University, Perth, Australia

    Background/Purpose: Osteoarthritis (OA) is a painful, progressive disease of synovial joints characterised by deterioration of cartilage and bone and inflammation. Osteoarthritis of the knee and…
  • Abstract Number: 1517 • 2012 ACR/ARHP Annual Meeting

    TLR9 Signaling in Fibroblasts Promotes Pro-Fibrotic Responses Via TGF-Beta

    Yang Yang1, Feng Fang2, Lei Liu1, Junjie Shangguan3, Boping Ye1 and John Varga3, 1School of Life Science and Technology, China Pharmaceutical University, Nanjing, China, 2Rheumatology Division, Northwestern University, Chicago, IL, 3Division of Rheumatology, Northwestern University, Chicago, IL

    Background/Purpose: Systemic sclerosis (SSc) is associated with progressive fibrosis and transforming growth factor β (TGF-β) is implicated in its pathogenesis. Toll-like receptors (TLR) respond to…
  • Abstract Number: 1518 • 2012 ACR/ARHP Annual Meeting

    Damage-Associated Endogenous TLR4 Ligand Fibronectin-EDA Is Overexpressed in Scleroderma and Drives Persistent Fibrosis Via TLR4 and Inhibition of TLR4 Prevents and Reverses Experimental Dermal Fibrosis: Novel Target for Scleroderma Therapy

    Swati Bhattacharyya1, Zenshiro Tamaki2, Wenxia Wang3, Paul Hoover4, Adam Booth5, Alyssa Dreffs6, Monique E. Hinchcliff7, Feng Fang8, Spiro Getsios4, Hang Yin9, Eric S. White6 and John Varga10, 1Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2Medicine, Rheumatology, Northwestern Univ Med School, Chicago, IL, Chicago, IL, 3Medicine/Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 4Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, 5Ann Arbor, MI, 6Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI, 7Division of Rheumatology, Northwestern Univ Med School, Chicago, IL, 8Rheumatology Division, Northwestern University, Chicago, IL, 9University of Colorado at Boulder, Boulder, CO, 10Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Recent studies implicate innate immune signaling and Toll like receptor-4 (TLR4) in fibrogenesis. We hypothesized that injury in scleroderma leads to tissue accumulation of…
  • Abstract Number: 1519 • 2012 ACR/ARHP Annual Meeting

    Heterogeneous Nuclear RNP-K Is a Novel Cold-Related Autoantigen in Patients with Raynaud’s Phenomenon

    Satoshi Serada1, Minoru Fujimoto2 and Tetsuji Naka2, 1Laboratory for immune signal, National Institute of Biomedical Innovation, Laboratory for immune signal, Japan, Ibaraki, Japan, 2Laboratory for immune signal, National Institute of Biomedical Innovation, Ibaraki, Japan

    Background/Purpose: Raynaud’s phenomenon (RP) is a vasospastic disorder and shows discoloration of the fingers, toes, and occasionally other areas. RP affects 3-9% of the general…
  • Abstract Number: 1520 • 2012 ACR/ARHP Annual Meeting

    Role of 12/15-Lipoxygenase(LOX) in Patients with Systemic Sclerosis

    Hirahito Endo, Makoto Kabraki, Koutarou Shikano, Sei Muraoka, Nahoko Tanaka, Tatsuhiro Yamamoto, Kanako Kitahara, Kaichi Kaneko, Yoshie Kusunoki, Natsuko Kusunoki, Kenji Takagi, Tomoko Hasunuma and Shinichi Kawai, Division of Rheumatology, Department of Internal Medicine, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan

    Background/Purpose: Recently 12/15-lipoxygenase (LOX) and it’s metabolites have a prominent anti-fibrotic role during dermal fibrosis in scleroderma experimental model using 12/15-LOX deficient mice were reported…
  • « Previous Page
  • 1
  • …
  • 2317
  • 2318
  • 2319
  • 2320
  • 2321
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology